UCSF And BridgeBio Pharma Collaborate To Accelerate The Development Of Therapies For Genetic Diseases

Wednesday, December 23, 2020 1 min read

Key Takeaway: UCSF And BridgeBio Pharma Collaborate To Accelerate The Development Of Therapies For Genetic Diseases

Full Press Release Details

UCSF And BridgeBio Pharma Collaborate To Accelerate The Development Of Therapies For Genetic Diseases.